Patents by Inventor Mohamed R. Shalaby

Mohamed R. Shalaby has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tumor necrosis factor antagonists and their use
    Patent number: 5795967
    Abstract: Tumor necrosis factor antagonists are administered in therapeutically effective doses to suppress inflammatory immune-potentiated events. The antagonists of this invention typically are selected from among several classes but preferably are neutralizing antibodies directed against tumor necrosis factor. The antagonists are useful in suppressing transplantation immunity and in the treatment of autoimmune diseases.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: August 18, 1998
    Assignee: Genentech, Inc.
    Inventors: Bharat B. Aggarwal, Michael A. Palladino, Mohamed R. Shalaby
  • Tumor necrosis factor antagonists and their use
    Patent number: 5672347
    Abstract: Tumor necrosis factor antagonists are administered in therapeutically effective doses to suppress inflammatory immune-potentiated events. The antagonists of this invention typically are selected from among several classes but preferably are neutralizing antibodies directed against tumor necrosis factor. The antagonists are useful in suppressing transplantation immunity and in the treatment of autoimmune diseases.
    Type: Grant
    Filed: May 5, 1995
    Date of Patent: September 30, 1997
    Assignee: Genentech, Inc.
    Inventors: Bharat B. Aggarwal, Michael A. Palladino, Mohamed R. Shalaby